Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Cevostamab
Trade Name
Synonyms RO7187797|BFCR4350A
Drug Descriptions

Cevostamab (BFCR4350A) is a bispecific antibody that targets both FCRH5 and CD3, potentially resulting in increased anti-tumor immune response and tumor cell killing (Blood (2020) 136 (Supplement 1): 42–43).

DrugClasses CD3 Antibody 78
CAS Registry Number NA
NCIT ID C139549


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Cevostamab Cevostamab 0 2
Cevostamab + Lenalidomide + Tocilizumab Cevostamab Lenalidomide Tocilizumab 0 1
Cevostamab + RO7310729 + Tocilizumab Cevostamab RO7310729 Tocilizumab 0 1
Cevostamab + Tocilizumab Cevostamab Tocilizumab 0 3

Additional content available in CKB BOOST